Toyoshima, Yujiro
Nemoto, Kensaku
Matsumoto, Saki
Nakamura, Yusuke
Kiyotani, Kazuma https://orcid.org/0000-0002-9236-9061
Article History
Received: 9 July 2020
Revised: 10 July 2020
Accepted: 12 July 2020
First Online: 22 July 2020
Compliance with ethical standards
:
: YN is a stockholder and a scientific advisor of OncoTherapy Science, Inc. KK is a scientific advisor of Cancer Precision Medicine, Inc. This study is unrelated to the activity in these companies.